ACRS FY 2022 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$435M

FY 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$30M+340.1% YoY

Gross Profit

$18M59.8% margin

Operating Income

-$90M-302.0% margin

Net Income

-$87M-292.1% margin

EPS (Diluted)

$-1.33

Cash Flow

Operating Cash Flow

-$68M

Free Cash Flow

-$68M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$255M

Total Liabilities

$57M

Stockholders' Equity

$198M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$7M	+340.1%
Gross Profit	$18M	$2M	+768.8%
Operating Income	-$90M	-$90M	-0.1%
Net Income	-$87M	-$91M	+4.4%